Related Experiment Video

Updated: Jan 26, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

824

[Diabetes mellitus, coronary artery disease und heart disease (Update 2019)]

Martin Clodi1,2, Christoph H Saely3, Friedrich Hoppichler4

  • 1Abteilung für Innnere Medizin, Konventhospital der Barmherzigen Brüder Linz, 4021, Linz, Österreich. martin.clodi@jku.at.

Wiener Klinische Wochenschrift
|April 14, 2019
PubMed

Insights

Patients with cardiovascular disease need diabetes screening. Those with diabetes and cardiovascular disease require risk assessment. Metformin-resistant patients with atherosclerotic cardiovascular disease benefit from agents reducing major adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Cardiovascular disease (CVD) and diabetes mellitus (DM) are interconnected, increasing heart failure risk.
  • Effective management requires integrated screening and risk stratification strategies.
  • Current guidelines recommend specific interventions for high-risk patients.

Purpose of the Study:

  • To outline screening protocols for DM in CVD patients.
  • To detail enhanced cardiovascular risk stratification for patients with DM.
  • To recommend therapeutic adjustments for atherosclerotic cardiovascular disease (ASCVD) in DM patients.

Main Methods:

  • Literature review of current guidelines and clinical evidence.
  • Analysis of dynamic interactions between DM, CVD, and heart failure.
  • Evaluation of risk stratification biomarkers and clinical factors.

Main Results:

  • Screening for DM is crucial in all new cardiovascular disease diagnoses.
  • Comprehensive risk stratification is essential for diabetic patients with existing CVD.
  • Agents reducing major adverse cardiovascular events are recommended for metformin-intolerant ASCVD patients.

Conclusions:

  • Integrated management of DM and CVD is vital for reducing mortality.
  • Early screening and risk stratification improve patient outcomes.
  • Personalized therapeutic strategies are necessary for complex cardiovascular and metabolic conditions.

Keywords:
Coronary artery diseaseDiabetes mellitusHeart failureScreening

More Related Videos

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

7.2K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.5K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
958
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
409
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
238
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
358
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K